Back
Protagonist Therapeutics Vs. Lindsay Industry Stock Comparison
Buy
68
PTGX
Protagonist Therapeutics
Last Price:
34.61
Seasonality Move:
2.56%
Sell
36
LNN
Lindsay
Last Price:
115.34
Seasonality Move:
-0.28%
Buy
68
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $35.20. The Score for PTGX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Lindsay (LNN)
is a Sell
Is Lindsay a Buy, Sell or Hold?
- The current Lindsay [LNN] share price is $113.16. The Score for LNN is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- LNN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $35.20
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight selling pressure.
PTGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.89 | Buy |
Relative Strength Index (14 RSI): | 65.53 | Buy |
Chaikin Money Flow: | -101379 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.85 - 34.23) | Buy |
Bollinger Bands (100): | (26.59 - 31.79) | Buy |
LNN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.62 | Buy |
Relative Strength Index (14 RSI): | 45.98 | Sell |
Chaikin Money Flow: | -215564 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.72 - 119.18) | Sell |
Bollinger Bands (100): | (113.4 - 121.84) | Sell |
PTGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.61 | Buy |
20-day SMA: | 32.84 | Buy |
50-day SMA: | 29.94 | Buy |
200-day SMA: | 24.25 | Buy |
8-day EMA: | 33.23 | Buy |
20-day EMA: | 32.43 | Buy |
50-day EMA: | 30.79 | Buy |
200-day EMA: | 26.1 | Buy |
LNN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 116.57 | Sell |
20-day SMA: | 116.03 | Sell |
50-day SMA: | 116.56 | Sell |
200-day SMA: | 120.8 | Sell |
8-day EMA: | 117.5 | Sell |
20-day EMA: | 116.55 | Sell |
50-day EMA: | 116.63 | Sell |
200-day EMA: | 121.3 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
Lindsay Earnings Growth & LNN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.22 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.19 per share.
Protagonist Therapeutics Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lindsay Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |